BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27561827)

  • 21. Effect of intensive glycaemic control on endothelial progenitor cells in patients with long-standing uncontrolled type 2 diabetes.
    Lev EI; Singer J; Leshem-Lev D; Rigler M; Dadush O; Vaduganathan M; Battler A; Kornowski R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1153-62. PubMed ID: 23598596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What role for metformin in type 1 diabetes?
    Drug Ther Bull; 2018 Jul; 56(7):78-80. PubMed ID: 30008442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
    Pitocco D; Zaccardi F; Tarzia P; Milo M; Scavone G; Rizzo P; Pagliaccia F; Nerla R; Di Franco A; Manto A; Rocca B; Lanza GA; Crea F; Ghirlanda G
    Diabetes Obes Metab; 2013 May; 15(5):427-31. PubMed ID: 23167274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial.
    Kovacs CS; Seshiah V; Swallow R; Jones R; Rattunde H; Woerle HJ; Broedl UC;
    Diabetes Obes Metab; 2014 Feb; 16(2):147-58. PubMed ID: 23906415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke.
    Regueiro A; Cuadrado-Godia E; Bueno-Betí C; Diaz-Ricart M; Oliveras A; Novella S; Gené GG; Jung C; Subirana I; Ortiz-Pérez JT; Roqué M; Freixa X; Núñez J; Escolar G; Marrugat J; Hermenegildo C; Valverde MA; Roquer J; Sanchis J; Heras M
    J Mol Cell Cardiol; 2015 Mar; 80():146-55. PubMed ID: 25619946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The number of circulating endothelial progenitor cells in healthy individuals--effect of some anthropometric and environmental factors (a pilot study).
    Ruszkowska-Ciastek B; Sokup A; Leszcz M; Drela E; Stankowska K; Boinska J; Haor B; Ślusarz R; Lisewska B; Gadomska G; Kubica J; Rość D
    Adv Med Sci; 2015 Mar; 60(1):58-63. PubMed ID: 25437349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy.
    Madonna R; Renna FV; Lanuti P; Perfetti M; Marchisio M; Briguori C; Condorelli G; Manzoli L; De Caterina R
    PLoS One; 2017; 12(4):e0172800. PubMed ID: 28394933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metformin on glycaemic variability in combination with insulin in overweight/obese patients with type 1 diabetes.
    Poh Shean W; Chin Voon T; Long Bidin MBB; Adam NLB
    J R Coll Physicians Edinb; 2023 Jun; 53(2):94-103. PubMed ID: 37154572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients.
    Chen LL; Liao YF; Zeng TS; Yu F; Li HQ; Feng Y
    Endocrine; 2010 Oct; 38(2):266-75. PubMed ID: 20972736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating endothelial progenitor cells in malignant gliomas.
    Rafat N; Beck GCh; Schulte J; Tuettenberg J; Vajkoczy P
    J Neurosurg; 2010 Jan; 112(1):43-9. PubMed ID: 19522573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
    Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
    Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of metformin in type 2 diabetes patients treated with insulin.
    Wulffelé MG; Kooy A; Lehert P; Bets D; Oom JA; Borger van der Burg B; Donker AJ; Stehouwer CD
    Neth J Med; 2002 Jul; 60(6):249-52. PubMed ID: 12365468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
    Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
    Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Number of colony-forming unit-Hill colonies among children and teenagers with obesity, dyslipidemia and breastfeeding history.
    Salazar-Martinez E; Rodriguez-Valentin R; Albavera-Hernandez C; Carreon-Rodriguez A; Lazcano-Ponce E
    Nutr Metab Cardiovasc Dis; 2016 Jun; 26(6):534-40. PubMed ID: 27113291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.
    Shaffer RG; Greene S; Arshi A; Supple G; Bantly A; Moore JS; Mohler ER
    Cytometry B Clin Cytom; 2006 Mar; 70(2):56-62. PubMed ID: 16456866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of Circulating Endothelial Cells and Endothelial Progenitor Cells Using Multicolor Flow Cytometry in Patients with Thrombophilia.
    Řádek M; Babuňková E; Špaček M; Kvasnička T; Kvasnička J
    Acta Haematol; 2019; 142(2):113-119. PubMed ID: 30995655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.